Embla Medical hf Management
Management criteria checks 3/4
Embla Medical hf's CEO is Sveinn Solvason, appointed in Apr 2022, has a tenure of 2.58 years. total yearly compensation is $1.18M, comprised of 48.8% salary and 51.2% bonuses, including company stock and options. directly owns 0.016% of the company’s shares, worth DKK2.45M. The average tenure of the management team and the board of directors is 2.6 years and 15.8 years respectively.
Key information
Sveinn Solvason
Chief executive officer
US$1.2m
Total compensation
| CEO salary percentage | 48.8% |
| CEO tenure | 2.6yrs |
| CEO ownership | 0.02% |
| Management average tenure | 2.6yrs |
| Board average tenure | 15.8yrs |
Recent management updates
Recent updates
Results: Embla Medical hf. Beat Earnings Expectations And Analysts Now Have New Forecasts
Oct 25
Estimating The Intrinsic Value Of Embla Medical hf. (CPH:EMBLA)
Oct 17Do Embla Medical hf's (CPH:EMBLA) Earnings Warrant Your Attention?
Oct 02Embla Medical hf.'s (CPH:EMBLA) Share Price Matching Investor Opinion
Aug 22Earnings Beat: Embla Medical hf. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Jul 26Calculating The Fair Value Of Embla Medical hf. (CPH:EMBLA)
Jul 17Market Participants Recognise Embla Medical hf.'s (CPH:EMBLA) Earnings
May 14Embla Medical hf. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Apr 26A Look At The Fair Value Of Embla Medical hf. (CPH:OSSR)
Apr 10Is Össur hf (CPH:OSSR) Using Too Much Debt?
Mar 23Why Investors Shouldn't Be Surprised By Össur hf.'s (CPH:OSSR) P/E
Jan 21Calculating The Intrinsic Value Of Össur hf. (CPH:OSSR)
Jan 03Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly
Nov 28Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)
Nov 08A Look At The Fair Value Of Össur hf. (CPH:OSSR)
Sep 23We Think Össur hf (CPH:OSSR) Is Taking Some Risk With Its Debt
Aug 21Össur hf (CPH:OSSR) May Have Issues Allocating Its Capital
Jul 18Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 19% Below Its Share Price
Jun 14Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly
May 19Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively
Mar 14A Look At The Intrinsic Value Of Össur hf. (CPH:OSSR)
Jan 21These 4 Measures Indicate That Össur hf (CPH:OSSR) Is Using Debt Reasonably Well
Dec 22There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital
Dec 07Are Investors Undervaluing Össur hf. (CPH:OSSR) By 37%?
Sep 21Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)
Sep 02Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly
Aug 16Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 42% Above Its Share Price
Jun 16Össur hf (CPH:OSSR) Will Want To Turn Around Its Return Trends
Jun 01Does Össur hf (CPH:OSSR) Have A Healthy Balance Sheet?
May 08Össur hf (CPH:OSSR) Will Be Hoping To Turn Its Returns On Capital Around
Feb 22Analysts Have Made A Financial Statement On Össur hf.'s (CPH:OSSR) Yearly Report
Feb 03Calculating The Fair Value Of Össur hf. (CPH:OSSR)
Nov 25Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)
Oct 17Is Össur hf (CPH:OSSR) A Risky Investment?
Sep 28Calculating The Fair Value Of Össur hf. (CPH:OSSR)
Aug 21Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively
Jul 11Here's Why Össur hf (CPH:OSSR) Can Manage Its Debt Responsibly
May 28Calculating The Fair Value Of Össur hf. (CPH:OSSR)
May 07There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital
Mar 25We Think The Compensation For Össur hf.'s (CPH:OSSR) CEO Looks About Right
Mar 02We Think Össur hf (CPH:OSSR) Can Stay On Top Of Its Debt
Feb 22Does The Market Have A Low Tolerance For Össur hf.'s (CPH:OSSR) Mixed Fundamentals?
Feb 09CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$69m |
| Jun 30 2024 | n/a | n/a | US$61m |
| Mar 31 2024 | n/a | n/a | US$57m |
| Dec 31 2023 | US$1m | US$576k | US$58m |
| Sep 30 2023 | n/a | n/a | US$52m |
| Jun 30 2023 | n/a | n/a | US$45m |
| Mar 31 2023 | n/a | n/a | US$43m |
| Dec 31 2022 | US$780k | US$409k | US$43m |
Compensation vs Market: Sveinn's total compensation ($USD1.18M) is below average for companies of similar size in the Danish market ($USD1.97M).
Compensation vs Earnings: Sveinn's compensation has increased by more than 20% in the past year.
CEO
Sveinn Solvason (46 yo)
2.6yrs
Tenure
US$1,180,000
Compensation
Mr. Sveinn Solvason had been Chief Financial Officer of Embla Medical hf. (formerly known as ssur hf.) since May 2013 until April 1, 2022 and serves as its President & CEO since April 1, 2022.Mr. Solvaso...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & CEO | 2.6yrs | US$1.18m | 0.016% DKK 2.4m | |
| Founder | no data | US$25.00k | no data | |
| Chief Financial Officer | 2.2yrs | no data | no data | |
| Chief Operating Officer | 1.4yrs | no data | no data | |
| Investor Relations Director | no data | no data | no data | |
| Executive Vice President of People | no data | US$242.00k | 0.0083% DKK 1.2m | |
| Chief Commercial Officer | no data | US$600.00k | 0.0030% DKK 452.1k | |
| Executive Vice President of EMEA & APAC | 7yrs | no data | 0.023% DKK 3.5m | |
| President of Americas | no data | no data | 0.0031% DKK 465.7k | |
| Executive Vice President of Research & Development | 2.6yrs | no data | 0.00014% DKK 21.1k |
2.6yrs
Average Tenure
50yo
Average Age
Experienced Management: EMBLA's management team is considered experienced (2.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board | 19.8yrs | US$108.00k | 0.048% DKK 7.2m | |
| Vice Chairman of the Board | 16.8yrs | US$72.00k | no data | |
| Independent Director | 11.7yrs | US$43.00k | 0.0062% DKK 928.4k | |
| Director | 15.8yrs | US$50.00k | no data | |
| Independent Director | 3.7yrs | US$43.00k | no data |
15.8yrs
Average Tenure
67yo
Average Age
Experienced Board: EMBLA's board of directors are seasoned and experienced ( 15.8 years average tenure).